ATE44234T1 - Zusammensetzungen zur therapeutischen verwendung mit gehalt an organo-silizium-verbindungen. - Google Patents
Zusammensetzungen zur therapeutischen verwendung mit gehalt an organo-silizium-verbindungen.Info
- Publication number
- ATE44234T1 ATE44234T1 AT85450004T AT85450004T ATE44234T1 AT E44234 T1 ATE44234 T1 AT E44234T1 AT 85450004 T AT85450004 T AT 85450004T AT 85450004 T AT85450004 T AT 85450004T AT E44234 T1 ATE44234 T1 AT E44234T1
- Authority
- AT
- Austria
- Prior art keywords
- therapeutic use
- osir3
- sigma
- branched
- saturated
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 150000003961 organosilicon compounds Chemical class 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 abstract 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 abstract 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 229910052804 chromium Inorganic materials 0.000 abstract 1
- 239000011651 chromium Substances 0.000 abstract 1
- -1 cyclic aliphatic compound Chemical class 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 229910052732 germanium Inorganic materials 0.000 abstract 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 abstract 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052737 gold Inorganic materials 0.000 abstract 1
- 239000010931 gold Substances 0.000 abstract 1
- 229910052735 hafnium Inorganic materials 0.000 abstract 1
- VBJZVLUMGGDVMO-UHFFFAOYSA-N hafnium atom Chemical compound [Hf] VBJZVLUMGGDVMO-UHFFFAOYSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 229910052741 iridium Inorganic materials 0.000 abstract 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 230000011278 mitosis Effects 0.000 abstract 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 abstract 1
- 229910052762 osmium Inorganic materials 0.000 abstract 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 abstract 1
- 229910052697 platinum Inorganic materials 0.000 abstract 1
- 229910052761 rare earth metal Inorganic materials 0.000 abstract 1
- 229910052703 rhodium Inorganic materials 0.000 abstract 1
- 239000010948 rhodium Substances 0.000 abstract 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052719 titanium Inorganic materials 0.000 abstract 1
- 239000010936 titanium Substances 0.000 abstract 1
- 125000005289 uranyl group Chemical group 0.000 abstract 1
- 229910052720 vanadium Inorganic materials 0.000 abstract 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 abstract 1
- 229910052726 zirconium Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/242—Gold; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8402120A FR2559063B1 (fr) | 1984-02-08 | 1984-02-08 | Compositions a usage therapeutique comprenant des composes organo-silicies |
| EP85450004A EP0152366B1 (de) | 1984-02-08 | 1985-02-08 | Zusammensetzungen zur therapeutischen Verwendung mit Gehalt an Organo-Silizium-Verbindungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE44234T1 true ATE44234T1 (de) | 1989-07-15 |
Family
ID=9300965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT85450004T ATE44234T1 (de) | 1984-02-08 | 1985-02-08 | Zusammensetzungen zur therapeutischen verwendung mit gehalt an organo-silizium-verbindungen. |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4994445A (de) |
| EP (1) | EP0152366B1 (de) |
| AT (1) | ATE44234T1 (de) |
| CA (1) | CA1255590A (de) |
| DE (1) | DE3571198D1 (de) |
| FR (1) | FR2559063B1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3929411A1 (de) * | 1988-09-22 | 1990-03-29 | Siegfried Natterer | Pharmazeutische zubereitung sowie verfahren zu ihrer herstellung |
| EP0407623A1 (de) * | 1989-02-01 | 1991-01-16 | Institut Fizicheskoi Khimii Imeni L.V.Pisarzhevskogo Akademii Nauk Ukrainskoi Ssr | Derivate von platin (p) mit methylsilikon, verfahren zur herstellung und anti-tumor-agens daraus |
| AU5448490A (en) * | 1989-04-24 | 1990-11-16 | Board Of Regents, The University Of Texas System | Compositions and processes for improving the cosmetic appearance, growths or healing characteristics of tissue |
| WO1996011011A1 (fr) * | 1993-10-12 | 1996-04-18 | Didier Lustig | Composition a base d'elements transuraniens pour le traitement homeopathique du s.i.d.a. |
| US6642221B1 (en) * | 2000-11-15 | 2003-11-04 | Parker Hughes Institute | Vanadium compounds as anti-proliferative agents |
| US20030022206A1 (en) * | 2001-05-16 | 2003-01-30 | Kay Robert A. | Method of characterizing a homeopathic preparation |
| PL239956B1 (pl) | 2018-12-10 | 2022-01-31 | Jednostka Innowacyjno Wdrozeniowa Inwex Spolka Z Ograniczona Odpowiedzialnoscia | Kompleksowe związki krzemu organicznego, sposób otrzymywania kompleksowych związków krzemu organicznego oraz zastosowanie kompleksowych związków krzemu organicznego |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA828140A (en) * | 1969-11-25 | Kai-Ching Yen John | Silicone compositions and method of preparing same | |
| FR1069M (fr) * | 1960-08-31 | 1962-01-22 | Charles Henri | Complexe organo-silicique. |
| FR2086M (fr) * | 1962-07-19 | 1963-10-21 | Rech S Pharma Et Scient | Médicament a base de silicone et farine de caroube ou autre substance gélifiante. |
| FR2158068B1 (de) * | 1971-10-25 | 1975-02-07 | Gueyne Jean | |
| FR2160293A1 (en) * | 1971-11-18 | 1973-06-29 | Gueyne Jean | Aqueous poly(1,1'-dimethyl-1-sila-2,6-dioxa-4-hexanol) compsn - with antiinflammatory and reticuloendothelial activity |
| FR2230376A1 (en) * | 1973-05-24 | 1974-12-20 | Gueyne Jean | Stable solutions of siloxanic polysilanols - prepd. by hydrolysis of a silane and having pharmaceutical activity |
| CA1139221A (en) * | 1978-10-10 | 1983-01-11 | Vijay B. Surpuriya | Antacid compositions |
| JPS5622732A (en) * | 1979-08-03 | 1981-03-03 | Shin Etsu Chem Co Ltd | Antitumor agent composed mainly of organic silicon compound |
| JPS5626910A (en) * | 1979-08-13 | 1981-03-16 | Japan Atom Energy Res Inst | Preparation of slow-release anticancer complex composition |
-
1984
- 1984-02-08 FR FR8402120A patent/FR2559063B1/fr not_active Expired
-
1985
- 1985-02-07 CA CA000473783A patent/CA1255590A/fr not_active Expired
- 1985-02-08 DE DE8585450004T patent/DE3571198D1/de not_active Expired
- 1985-02-08 EP EP85450004A patent/EP0152366B1/de not_active Expired
- 1985-02-08 AT AT85450004T patent/ATE44234T1/de not_active IP Right Cessation
-
1990
- 1990-03-22 US US07/498,444 patent/US4994445A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0152366B1 (de) | 1989-06-28 |
| US4994445A (en) | 1991-02-19 |
| DE3571198D1 (en) | 1989-08-03 |
| EP0152366A2 (de) | 1985-08-21 |
| FR2559063A1 (fr) | 1985-08-09 |
| CA1255590A (fr) | 1989-06-13 |
| EP0152366A3 (en) | 1988-01-27 |
| FR2559063B1 (fr) | 1987-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ185832A (en) | Pharmaceutical composition for the treatment of urogenital disorders extract from plant(s) of rosaceae family plus mono-aminated amino acids | |
| ES485540A1 (es) | Procedimiento para la obtencion de 1,4-dihidropiridinas, congrupos ester funcionalizados | |
| DE3789576D1 (de) | Verwendung von Inositol-Triphosphat zur Behandlung von Metallvergiftung. | |
| FR2571966B1 (fr) | Compositions therapeutiques contenant des anthracyclines-glucosides. | |
| DE3788629D1 (de) | Neue malonsäurederivate und zusammensetzungen, die sie enthalten, zur verzögerung des pflanzenwachstums. | |
| DE3364779D1 (en) | Substituted 4-aminomethylene chromans or chromenes, process for their preparation and their use in medicines | |
| ATE25525T1 (de) | N-glycosylierte carbonsaeureamid-derivate, verfahren zu ihrer herstellung sowie ihre verwendung zur beeinflussung der koerpereigenen abwehr. | |
| IT1209302B (it) | Composizione saponificante contenente composti al silicio quali ingredienti profumati di lunga durata | |
| DE3176215D1 (en) | Non-yellowing topical pharmaceutical composition | |
| DE3584560D1 (de) | Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen. | |
| GR851777B (de) | ||
| ES8701761A1 (es) | Un procedimiento para la preparacion de derivados de podofilotoxina. | |
| ATE44234T1 (de) | Zusammensetzungen zur therapeutischen verwendung mit gehalt an organo-silizium-verbindungen. | |
| DE2861081D1 (en) | 2,5,7-trimethyloctane-3-ol and 2,4-dimethylnonane-8-ol; processes for their preparation; their use as olfactory agents; olfactory compositions containing them, as well as the preparation of such olfactory compositions | |
| ATE45286T1 (de) | Gammainterferon und lymphotoxin enthaltende synergistische zusammensetzung und ihre herstellung. | |
| AT374483B (de) | Neue zusammensetzungen zur bekaempfung von pflanzenkrankheiten | |
| ATE14982T1 (de) | Zusammensetzungen mit gehalt an paromomycin zur oertlichen behandlung der leishmaniasis der haut. | |
| DE69112747D1 (de) | Inhibitoren der Calciumaufnahme. | |
| ATE70444T1 (de) | Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen. | |
| IT7821264A0 (it) | Composizione per il trattamento dell'asma. | |
| JPS5398968A (en) | Novel 2*44dichlorophenylltriazolyllethaneeone and ol* its production and fungicidal compositions containing same as active component | |
| IT8147718A0 (it) | Composizione per regolare umidita'corporea derivante da traspirazione | |
| JPS57106676A (en) | Methyl-4-oxatricyclo(5,2,1,0*2,6)-dec-8- ene-3-one or methyl-4-oxatricyclo(5,2,1,0*2,6)- decane-3-one, manufacture and perfume or perfume composition consisting thereof | |
| IT8125874A0 (it) | Composizioni terapeutiche adattivita' coleretica contenenti come principio attivo derivati dall'acido colanico. | |
| JPS56154456A (en) | S-alkyl-3-alkylthiopropionothioates, nanufacture and medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |